Method for treatment of myasthenia gravis

The disclosure relates to a method of treating or preventing Myasthenia Gravis (MG) in a human in need thereof using an anti-FcRn antibody or antigen binding fragment thereof. In particular, the method provides suitable dosage regimens for such treatment. 本公开涉及使用抗FcRn抗体或其抗原结合片段在有此需要的人中治疗或预防重症肌无力(MG)...

Full description

Saved in:
Bibliographic Details
Main Authors BROCK MELISSA KAYE, KIESSLING CLAUS PETER, LANGDON GRANT, GREVE BERNHARD HEINRICH, WEBSTER MANIS ELIZABETH, BYRNES WILLIAM JAMES
Format Patent
LanguageChinese
English
Published 12.11.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to a method of treating or preventing Myasthenia Gravis (MG) in a human in need thereof using an anti-FcRn antibody or antigen binding fragment thereof. In particular, the method provides suitable dosage regimens for such treatment. 本公开涉及使用抗FcRn抗体或其抗原结合片段在有此需要的人中治疗或预防重症肌无力(MG)的方法。特别地，该方法为这种治疗提供了合适的剂量方案。
Bibliography:Application Number: CN20198077400